EVIDENCE TAKEAWAY
The short answer.
AOD-9604 is a useful example of why preclinical promise is not enough: substantial human development did not produce persuasive efficacy or an approved obesity indication.
WHAT IS AOD-9604?
Start with identity.
A synthetic fragment of human growth hormone investigated for metabolic effects, with limited human evidence.
- Entity type
- Peptide fragment
- Research category
- Weight & Metabolism
- Names and aliases
- AOD-9604
HUMAN VS PRECLINICAL
What evidence exists for AOD-9604?
A sizable randomized phase 2 obesity program was conducted, but FDA's review notes the results did not support commercial development.
Preclinical lipolysis and weight-related signals did not translate into an approved obesity medicine.
RESEARCH INTENT
What is AOD-9604 being studied for?
Current source-backed research areas include the topics below. Inclusion means the area is being investigated; it does not establish a treatment benefit.
- 01Obesity
- 02Lipolysis
- 03Growth hormone fragments
- 04Cartilage research
U.S. REGULATORY STATUS
Is AOD-9604 FDA approved?
No FDA-approved AOD-9604 drug product; FDA identifies limited safety information and potential concerns for compounded use.
SPORT STATUS
Is AOD-9604 prohibited in sport?
Prohibited at all times under the 2026 WADA List (S2) as a growth-hormone fragment.
Anti-doping rules and product ingredients can change. Athletes should verify the current official list and the exact product before making a real decision.
EVIDENCE LIMITS
What can the current record not establish?
COMMON SEARCH INTENTS
Reviewed questions about AOD-9604.
What is the evidence for AOD-9604?
AOD-9604 is a useful example of why preclinical promise is not enough: substantial human development did not produce persuasive efficacy or an approved obesity indication.
3 sources ResearchWhat is AOD-9604 being studied for?
Current source-backed research areas include Obesity, Lipolysis, Growth hormone fragments, Cartilage research. These areas describe investigation, not established personal benefit.
3 sources FDA statusIs AOD-9604 FDA approved?
Current U.S. status for AOD-9604: No FDA-approved AOD-9604 drug product; FDA identifies limited safety information and potential concerns for compounded use.
3 sources Sport statusIs AOD-9604 prohibited in sport?
Current sport-status snapshot for AOD-9604: Prohibited at all times under the 2026 WADA List (S2) as a growth-hormone fragment.
3 sources Evidence limitsWhat are the main evidence limits for AOD-9604?
The existence of a large trial should not be summarized as positive evidence when the development result was not clinically persuasive.
3 sourcesPRIMARY AND OFFICIAL SOURCES